Mycoplasmas in swine
Latest Publications


TOTAL DOCUMENTS

14
(FIVE YEARS 14)

H-INDEX

0
(FIVE YEARS 0)

Published By CABI

9781789249941

2021 ◽  
pp. 147-161
Author(s):  
Chan-hee Chae ◽  
João Carlos Gomes Neto ◽  
Joaquim Segalés ◽  
Marina Sibila

Abstract In this chapter, the different diagnostic techniques available for Mycoplasma hyopneumonia in growing and/or finishing animals alongside their advantages and limitations are reviewed.


2021 ◽  
pp. 25-46
Author(s):  
Andrew Rycroft
Keyword(s):  

Abstract This chapter describes the phylogenetics, culture and pathogenicity of Mycoplasma species in pigs.


2021 ◽  
pp. 97-107
Author(s):  
John Carr ◽  
Marina Sibila ◽  
Joaquim Segalés

Abstract The clinical signs, pathogenesis, diagnosis and pathological features of Mycoplasma hyopneumoniae infection in pigs are described.


2021 ◽  
pp. 207-228
Author(s):  
Dominiek Maes ◽  
Filip Boyen ◽  
Odir Dellagostin ◽  
Guo-qing Shao ◽  
Freddy Haesebrouck

Abstract This chapter reviews the current knowledge on vaccination of pigs against Mycoplasma hyopneumoniae, including the currently available vaccines and their effects, the mechanisms of protection, the different vaccination strategies and the different experimental vaccines that have been developed to further improve the efficacy of vaccination.


2021 ◽  
pp. 181-205
Author(s):  
Anne V. Gautier-Bouchardon

Abstract This chapter reviews the antimicrobials and antimicrobial treatments used to control M. hyopneumoniae infections. It also gives an overview of in vitro and in vivo activities of these antimicrobials and of resistance mechanisms described for M. hyopneumoniae towards these antimicrobials.


2021 ◽  
pp. 267-283
Author(s):  
Ludwig E. Hoelzle

Abstract This chapter describes the biochemistry and genetic caharacteristics, epidemiology, prevalence, transmission, pathogenesis, clinical signs, diagnosis, treatment, prevention, control and socioeconomic impact of Mycoplasma suis infection in pigs.


2021 ◽  
pp. 47-71
Author(s):  
Veronica M. Jarocki ◽  
Steven P. Djordjevic

Abstract This chapter provides a summary of the literature regarding diversity in Mycoplasma hyopneumoniae strains, pointing out discrepancies, and highlighting that there is still much to be gleaned from this genome reduced, yet highly complex pathogen.


2021 ◽  
pp. 109-125
Author(s):  
Artur Summerfield

Abstract This chapter presents current knowledge on the pathogenesis and immune responses against Mycoplasma hyopneumoniae infection in pigs and mice based on studies acquired from other Mycoplasma infections.


2021 ◽  
pp. 87-96
Author(s):  
Maria Pieters ◽  
Alyssa Betlach ◽  
Heiko Nathues ◽  
Dominiek Maes

Abstract This chapter focused on the aspects related to prevalence, infection dynamics, transmission, risk factors, and distribution of M. hyopneumoniae.


2021 ◽  
pp. 163-180
Author(s):  
Enric Marco ◽  
Paul Yeske ◽  
Maria Pieters

Abstract This chapter focused on the control of M. hyopneumoniae aside from antibiotic treatment and vaccine application, also an overview of the most prominent factors affecting M. hyopneumoniae disease development and clinical presentation are discussed in detail in different sections of this chapter.


Sign in / Sign up

Export Citation Format

Share Document